Blood Gas & Electrolyte Analyzer Market Size to Surpass US$ 2.71 Billion by 2031 – Growth Plus Reports

Newark, New Castle, USA, May 19, 2023 (GLOBE NEWSWIRE) — According to a recent Growth Plus Reports study, the blood gas & electrolyte analyzer market was valued at US$ 1.78 billion in 2022. The market is likely to register a revenue CAGR of 4.78% and reach US$ 2.71 billion by 2031. The study examines the important strategies, drivers and prospects, competitive circumstances, shifting market dynamics, market size, data and forecasts, and important investment regions.

Key Takeaways:

• The rising number of patients requiring blood sample testing will drive market revenue growth.
• The rise in the prevalence of chronic and infectious diseases will drive demand for blood gas & electrolyte analyzers.
• North America dominates the global blood gas & electrolyte analyzer market. 

Request a Free Sample Copy of the Research Report:  https://www.growthplusreports.com/inquiry/request-sample/blood-gas-electrolyte-analyzer-market/8354

                           Blood Gas & Electrolyte Analyzer Market Scope

Market Drivers
The increasing use of blood gas analysis at hospital point-of-care settings for quick and accurate results will drive the market’s revenue growth. Furthermore, technological advancements, a growth in the number of patients requiring blood sample testing, and an increasing prevalence of heart disease, vascular disease, and diabetes are expected to fuel the market’s revenue growth. Apart from this, the growing geriatric population vulnerable to chronic and infectious diseases is expected to support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global blood gas & electrolyte analyzer market from four perspectives: Modality, Product, End User, and Region.

• Based on the Modality, the blood gas & electrolyte analyzer market is segmented into bench top and portable.
• Based on the Product, the blood gas & electrolyte analyzer market is segmented into analyzers and consumables.
• Based on the End User, the blood gas & electrolyte analyzer market is segmented into hospitals, central laboratories, point-of-care, diagnostic centers, and others.

Product Segmentation
Based on the product, the blood gas & electrolyte analyzer market is segmented into two categories: analyzers and consumables. Consumables dominate the market since they include reagents, kits, and disposables that are required for blood gas and electrolyte testing.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/blood-gas-electrolyte-analyzer-market/8354

Regional Growth Dynamics
Based on the region, the global blood gas & electrolyte analyzer market is segmented into North America, Europe, Latin America, and the Middle East & Africa. North America dominates the blood gas & electrolyte analyzer market with the largest revenue share because of the advanced healthcare services, the availability of numerous treatment options, the presence of major players in the market, the growing demand for portable point-of-care devices with wireless connectivity, and the rising prevalence of lifestyle disorders.

Competitive Landscape

The top companies in the global blood gas & electrolyte analyzer market are:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Medica Corporation
• Siemens Healthcare 
• Edan Instruments Inc.
• Convergent Technologies GmbH & Co. KG
• Radiometer Medical 
• OPTI Medical Systems
• Alere Inc.
• Advanz Pharmaceuticals

The antisense oligonucleotide market is moderately competitive, with numerous international corporations involved. To expand their product portfolio, key players prioritize R&D.

Recent Developments:

• Sysmex America Inc., a diagnostics solutions company, gained FDA authorization in June 2022 to add a new feature to its N-10 Automated Hematology Analyzer with Blood Bank mode. 
• ENVEA launched their revolutionary portable multi-gas monitor MIR 9000P in January 2021, designed to meet the unique requirements of regulatory and periodic monitoring.
• Nova Biomedical FLEX2 Cell Culture Analyzer enhanced sample retention capacity to its existing product in January 2021 for improved results and market sales.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL BLOOD GAS & ELECTROLYTE ANALYZER MARKET- ANALYSIS & FORECAST, BY MODALITY
   1. Bech Top 
   2. Portable
6. GLOBAL BLOOD GAS & ELECTROLYTE ANALYZER MARKET- ANALYSIS & FORECAST, BY PRODUCT
   1. Analyzer
      1. Blood Gas Analyzers
      2. Electrolyte Analyzers
      3. Combined Analyzers
   2. Consumables
7. GLOBAL BLOOD GAS & ELECTROLYTE ANALYZER MARKET- ANALYSIS & FORECAST, BY END-USER
   1. Hospitals
   2. Central Laboratories
   3. Point-of-Care
   4. Diagnostic Centers
   5. Others

BLOOD GAS & ELECTROLYTE ANALYZER MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8354

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Life Support Systems Market by Device Type (Ventilators, Extracorporeal Oxygenator), End User (Trauma Centers, Hospitals) – Global Outlook & Forecast 2023-2031

Protein Labeling Market by Product (Reagents, Kits), Labeling Method (In-Vivo Labeling, In-Vitro Labeling), Application (Protein Microarray, Mass Spectrometry), End User (Hospitals, Biopharmaceutical Companies) – Global Outlook & Forecast 2023-2031

Automated Visual Field Analyzer Market by Type (Static, Kinetic), Application (Glaucoma, Age-related Macular Degeneration, Scotoma, Others), End User (Hospitals, Eye Clinics) – Global Outlook & Forecast 2023-2031

Bone Metabolism Test Market by Test Types (Bone Marker Test, Immunoassay), Application (Hyperparathyroidism, Hypoparathyroidism) – Global Outlook & Forecast 2023-2031

Transient Elastography Device Market by Technology (Vibration Controlled Transient Elastography and Controlled Attenuation Parameter), Modality (Standalone and Portable), End User (Hospitals, Diagnostics Centers) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.